These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 34052828)

  • 21. Elevated tumor necrosis factor-alpha receptor subtype 1 and the association with abnormal brain function in treatment-resistant depression.
    Huang MH; Chen MH; Tu PC; Bai YM; Su TP; Yang BH; Liu RS; Li CT
    J Affect Disord; 2018 Aug; 235():250-256. PubMed ID: 29660639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative assessment of translocator protein (TSPO) in the non-human primate brain and clinical translation of [
    Tan Z; Haider A; Zhang S; Chen J; Wei J; Liao K; Li G; Wei H; Dong C; Ran W; Li Y; Li Y; Rong J; Li Y; Liang SH; Xu H; Wang L
    Pharmacol Res; 2023 Mar; 189():106681. PubMed ID: 36746361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated Monoamine Oxidase-A Distribution Volume in Borderline Personality Disorder Is Associated With Severity Across Mood Symptoms, Suicidality, and Cognition.
    Kolla NJ; Chiuccariello L; Wilson AA; Houle S; Links P; Bagby RM; McMain S; Kellow C; Patel J; Rekkas PV; Pasricha S; Meyer JH
    Biol Psychiatry; 2016 Jan; 79(2):117-26. PubMed ID: 25698585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TSPO expression and brain structure in the psychosis spectrum.
    Hafizi S; Guma E; Koppel A; Da Silva T; Kiang M; Houle S; Wilson AA; Rusjan PM; Chakravarty MM; Mizrahi R
    Brain Behav Immun; 2018 Nov; 74():79-85. PubMed ID: 29906515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minocycline as an adjunct for treatment-resistant depressive symptoms: A pilot randomised placebo-controlled trial.
    Husain MI; Chaudhry IB; Husain N; Khoso AB; Rahman RR; Hamirani MM; Hodsoll J; Qurashi I; Deakin JF; Young AH
    J Psychopharmacol; 2017 Sep; 31(9):1166-1175. PubMed ID: 28857658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain translocator protein occupancy by ONO-2952 in healthy adults: A Phase 1 PET study using [
    Frankle WG; Narendran R; Wood AT; Suto F; Himes ML; Kobayashi M; Ohno T; Yamauchi A; Mitsui K; Duffy K; Bruce M
    Synapse; 2017 Jul; 71(7):. PubMed ID: 28245513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction between TSPO-a neuroimmune marker-and redox status in clinical high risk for psychosis: a PET-MRS study.
    Hafizi S; Da Silva T; Meyer JH; Kiang M; Houle S; Remington G; Prce I; Wilson AA; Rusjan PM; Sailasuta N; Mizrahi R
    Neuropsychopharmacology; 2018 Jul; 43(8):1700-1705. PubMed ID: 29748630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [
    Sridharan S; Raffel J; Nandoskar A; Record C; Brooks DJ; Owen D; Sharp D; Muraro PA; Gunn R; Nicholas R
    Mol Imaging Biol; 2019 Oct; 21(5):935-944. PubMed ID: 30796709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoamine Oxidase B Total Distribution Volume in the Prefrontal Cortex of Major Depressive Disorder: An [11C]SL25.1188 Positron Emission Tomography Study.
    Moriguchi S; Wilson AA; Miler L; Rusjan PM; Vasdev N; Kish SJ; Rajkowska G; Wang J; Bagby M; Mizrahi R; Varughese B; Houle S; Meyer JH
    JAMA Psychiatry; 2019 Jun; 76(6):634-641. PubMed ID: 30840042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigating TSPO levels in occupation-related posttraumatic stress disorder.
    Watling SE; Gill T; Gaudette EV; Richardson JD; McCluskey T; Tong J; Meyer JH; Warsh J; Jetly R; Hutchison MG; Rhind SG; Houle S; Kish SJ; Boileau I
    Sci Rep; 2023 Mar; 13(1):4970. PubMed ID: 36973385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GABA levels and TSPO expression in people at clinical high risk for psychosis and healthy volunteers: a PET-MRS study.
    Da Silva T; Hafizi S; Rusjan PM; Houle S; Wilson AA; Prce I; Sailasuta N; Mizrahi R
    J Psychiatry Neurosci; 2019 Mar; 44(2):111-119. PubMed ID: 30255837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minocycline as an adjunct for treatment-resistant depressive symptoms: study protocol for a pilot randomised controlled trial.
    Husain MI; Chaudhry IB; Rahman RR; Hamirani MM; Qurashi I; Khoso AB; Deakin JF; Husain N; Young AH
    Trials; 2015 Sep; 16():410. PubMed ID: 26374703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: A randomized controlled study.
    Li CT; Chen MH; Lin WC; Hong CJ; Yang BH; Liu RS; Tu PC; Su TP
    Hum Brain Mapp; 2016 Mar; 37(3):1080-90. PubMed ID: 26821769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TSPO PET Identifies Different Anti-inflammatory Minocycline Treatment Response in Two Rodent Models of Epileptogenesis.
    Wolf BJ; Brackhan M; Bascuñana P; Leiter I; Langer BLN; Ross TL; Bankstahl JP; Bankstahl M
    Neurotherapeutics; 2020 Jul; 17(3):1228-1238. PubMed ID: 31970667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects.
    Richards EM; Zanotti-Fregonara P; Fujita M; Newman L; Farmer C; Ballard ED; Machado-Vieira R; Yuan P; Niciu MJ; Lyoo CH; Henter ID; Salvadore G; Drevets WC; Kolb H; Innis RB; Zarate CA
    EJNMMI Res; 2018 Jul; 8(1):57. PubMed ID: 29971587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imaging the Influence of Red Blood Cell Docosahexaenoic Acid Status on the Expression of the 18 kDa Translocator Protein in the Brain: A [
    Tollefson S; Himes ML; Kozinski KM; Lopresti BJ; Mason NS; Hibbeln J; Muldoon MF; Narendran R
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2022 Oct; 7(10):998-1006. PubMed ID: 34607054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. State-associated changes in longitudinal [
    De Picker L; Ottoy J; Verhaeghe J; Deleye S; Wyffels L; Fransen E; Kosten L; Sabbe B; Coppens V; Timmers M; de Boer P; Van Nueten L; Op De Beeck K; Oberacher H; Vanhoenacker F; Ceyssens S; Stroobants S; Staelens S; Morrens M
    Brain Behav Immun; 2019 Mar; 77():46-54. PubMed ID: 30503836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antidepressant and antisuicidal effects of ketamine on the functional connectivity of prefrontal cortex-related circuits in treatment-resistant depression: A double-blind, placebo-controlled, randomized, longitudinal resting fMRI study.
    Chen MH; Lin WC; Tu PC; Li CT; Bai YM; Tsai SJ; Su TP
    J Affect Disord; 2019 Dec; 259():15-20. PubMed ID: 31437695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Moving Toward Multicenter Therapeutic Trials in Amyotrophic Lateral Sclerosis: Feasibility of Data Pooling Using Different Translocator Protein PET Radioligands.
    Van Weehaeghe D; Babu S; De Vocht J; Zürcher NR; Chew S; Tseng CJ; Loggia ML; Koole M; Rezaei A; Schramm G; Van Damme P; Hooker JM; Van Laere K; Atassi N
    J Nucl Med; 2020 Nov; 61(11):1621-1627. PubMed ID: 32169920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of the specific translocator protein signal of 18F-PBR111 in healthy humans: a genetic polymorphism effect on in vivo binding.
    Guo Q; Colasanti A; Owen DR; Onega M; Kamalakaran A; Bennacef I; Matthews PM; Rabiner EA; Turkheimer FE; Gunn RN
    J Nucl Med; 2013 Nov; 54(11):1915-23. PubMed ID: 24071511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.